[Elsevier] First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial |
Reward10points
Best Answer
2024-3-29
|
| |
10
Empowering TomorrowĄ¯s Gastroenterologists and Their Patients:Integrating Motivational Interviewing into Fellowship Training
10
Digital twin-enabled built environment sensing and monitoring through semantic enrichment of BIM with SensorML
10
A temporal perspective for tumor-associated macrophage identities and functions
10
A comparative study on modification of aerogel-based biosorbents from coconut fibers for treatment of dye- and oil-contaminated water
10
Resistive switching characteristics of TiO2 thin films for nonvolatile memory applications
